Company / Revenue
IGC Pharma, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.3M
FY2025
5-year range
$397.0K / $4.1M
FY2021-FY2025
Trend
+39.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $397,000 in FY2023 to $8M in FY2016.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -24.3%.
Improved from $397,000 to $1M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +12.3%
- 5-Year CAGR
- -24.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -24.3%, indicating a declining trend.
- In FY2025, revenue increased 39.5% year-over-year.
- Peak revenue was recorded in FY2016.
- Lowest revenue in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3M | +39.5% |
| FY2024 | $911.0K | +129.5% |
| FY2023 | $397.0K | -55.8% |
| FY2022 | $898.0K | -77.9% |
| FY2021 | $4.1M | -20.4% |
| FY2020 | $5.1M | +133.3% |
| FY2019 | $2.2M | +277.9% |
| FY2018 | $580.4K | -90.9% |
| FY2017 | $6.4M | -17.1% |
| FY2016 | $7.7M | +237.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026